Logo

VolitionRx

VolitionRx Awarded Additional $4 Million in Funding

The company said that part of the funding was an unsecured loan to support the analysis of tumor DNA using a nucleosome immunoprecipitation method.

VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays

The companies said Tuesday that they are pursuing a clinical trial utilizing their respective liquid biopsy assays on clinical samples from lung cancer patients.

VolitionRx Receives $700K in Funding From Regional Government

A portion of the funding, which is from the government of the Wallonia region of Belgium, is repayable over 12 years.

VolitionRx, Active Motif Sign Global Sales, Distribution Agreement

VolitonRx's research-use-only kits can be used to examine patterns in circulating nucleosomes in disease models, preclinical testing, and clinical trials.

VolitionRx Gets CE Mark for Colorectal Cancer Screening Test

The test combines two previously CE marked assays that are based on the company's Nucleosomics platform for identifying and quantifying nucleosome structural features.

Breaking News
The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.